GUARDANT HEALTH, INC. Financing Cash Flow
GUARDANT HEALTH, INC. (GH) reported Financing Cash Flow of $1.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-30
- GUARDANT HEALTH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $23.01M, a 1317.12% increase year-over-year.
- GUARDANT HEALTH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$21.58M.
- GUARDANT HEALTH, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $732.03M.
- GUARDANT HEALTH, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $4.33M.
- GUARDANT HEALTH, INC. net cash provided by (used in) financing activities for fiscal 2025 was $671.13M.
- GUARDANT HEALTH, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$996.00K, a 100.21% decline from fiscal 2023.
- GUARDANT HEALTH, INC. net cash provided by (used in) financing activities for fiscal 2023 was $477.38M.
- GUARDANT HEALTH, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$189.09M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.44M 10-Q · filed 2026-07-30 | $733.47M derived: sum of 3 quarters · filed 2026-07-30 | $737.80M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$21.58M 10-Q · filed 2026-05-07 | $710.45M derived: sum of 2 quarters · filed 2026-05-07 | $714.78M derived: sum of 3 quarters · filed 2026-05-07 | $716.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $732.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $736.36M derived: sum of 2 quarters · filed 2026-02-19 | $737.98M derived: sum of 3 quarters · filed 2026-07-30 | $671.13M 10-K · filed 2026-02-19 |
| 2025-09-30 | $4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $5.96M derived: sum of 2 quarters · filed 2026-07-30 | -$60.90M 10-Q · filed 2025-10-29 | -$63.83M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$65.23M 10-Q · filed 2026-07-30 | -$68.16M derived: sum of 3 quarters · filed 2026-07-30 | -$71.05M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$66.85M 10-Q · filed 2026-05-07 | -$69.78M derived: sum of 2 quarters · filed 2026-05-07 | -$72.67M derived: sum of 3 quarters · filed 2026-05-07 | -$66.77M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$5.82M derived: sum of 2 quarters · filed 2026-02-19 | $78.00K derived: sum of 3 quarters · filed 2026-02-19 | -$996.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | -$2.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.01M derived: sum of 2 quarters · filed 2025-10-29 | $1.94M 10-Q · filed 2025-10-29 | $92.51M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $4.82M 10-Q · filed 2025-07-30 | $95.39M derived: sum of 3 quarters · filed 2026-02-19 | $99.20M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$1.07M 10-Q · filed 2025-04-30 | $89.49M derived: sum of 2 quarters · filed 2026-02-19 | $93.30M derived: sum of 3 quarters · filed 2026-02-19 | $477.15M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $90.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $94.38M derived: sum of 2 quarters · filed 2026-02-19 | $478.23M derived: sum of 3 quarters · filed 2026-02-19 | $477.38M 10-K · filed 2026-02-19 |
| 2023-09-30 | $3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $387.66M derived: sum of 2 quarters · filed 2024-11-06 | $386.81M 10-Q · filed 2024-11-06 | $389.13M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $383.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $383.00M 10-Q · filed 2024-08-07 | $385.32M derived: sum of 3 quarters · filed 2025-02-20 | $366.01M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | -$854.00K 10-Q · filed 2024-05-09 | $1.46M derived: sum of 2 quarters · filed 2025-02-20 | -$17.85M derived: sum of 3 quarters · filed 2025-02-20 | -$189.94M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$16.99M derived: sum of 2 quarters · filed 2025-02-20 | -$189.08M derived: sum of 3 quarters · filed 2025-02-20 | -$189.09M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$19.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$191.40M derived: sum of 2 quarters · filed 2023-11-06 | -$191.41M 10-Q · filed 2023-11-06 | -$187.63M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$172.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$172.10M 10-Q · filed 2023-08-03 | -$168.32M derived: sum of 3 quarters · filed 2024-02-22 | -$173.88M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$12.00K 10-Q · filed 2023-05-09 | $3.77M derived: sum of 2 quarters · filed 2024-02-22 | -$1.79M derived: sum of 3 quarters · filed 2024-02-22 | $3.12M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$1.78M derived: sum of 2 quarters · filed 2024-02-22 | $3.13M derived: sum of 3 quarters · filed 2024-02-22 | -$66.82M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$5.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$651.00K derived: sum of 2 quarters · filed 2022-11-03 | -$70.60M 10-Q · filed 2022-11-03 | $976.12M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $4.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$65.04M 10-Q · filed 2022-08-04 | $981.68M derived: sum of 3 quarters · filed 2023-02-23 | $982.48M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$69.95M 10-Q · filed 2022-05-05 | $976.77M derived: sum of 2 quarters · filed 2023-02-23 | $977.57M derived: sum of 3 quarters · filed 2023-02-23 | $1.34B derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.05B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.05B derived: sum of 2 quarters · filed 2023-02-23 | $1.41B derived: sum of 3 quarters · filed 2023-02-23 | $1.41B 10-K · filed 2023-02-23 |
| 2020-09-30 | $797.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $362.12M derived: sum of 2 quarters · filed 2021-11-04 | $363.58M 10-Q · filed 2021-11-04 | $366.66M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $361.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $362.79M 10-Q · filed 2021-08-05 | $365.86M derived: sum of 3 quarters · filed 2022-02-24 | $372.73M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.47M 10-Q · filed 2021-05-06 | $4.54M derived: sum of 2 quarters · filed 2022-02-24 | $11.41M derived: sum of 3 quarters · filed 2022-02-24 | $366.48M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $9.95M derived: sum of 2 quarters · filed 2022-02-24 | $365.02M derived: sum of 3 quarters · filed 2022-02-24 | $367.30M 10-K · filed 2022-02-24 |
| 2019-09-30 | $6.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $361.94M derived: sum of 2 quarters · filed 2020-11-05 | $364.23M 10-Q · filed 2020-11-05 | $614.59M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $355.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $357.36M 10-Q · filed 2020-08-06 | $607.72M derived: sum of 3 quarters · filed 2021-02-25 | $608.52M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.29M 10-Q · filed 2020-05-07 | $252.65M derived: sum of 2 quarters · filed 2021-02-25 | $253.45M derived: sum of 3 quarters · filed 2021-02-25 | $294.18M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $250.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $251.16M derived: sum of 2 quarters · filed 2021-02-25 | $291.89M derived: sum of 3 quarters · filed 2021-02-25 | $293.16M 10-K · filed 2021-02-25 |
| 2018-09-30 | $796.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $41.53M derived: sum of 2 quarters · filed 2019-11-07 | $42.80M 10-Q · filed 2019-11-07 | $42.84M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $40.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $42.00M 10-Q · filed 2019-08-07 | $42.05M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2018-03-31 | $1.27M 10-Q · filed 2019-05-10 | $1.31M derived: sum of 2 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $281.66M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $281.61M 10-Q · filed 2018-11-19 | |||
| 2016-12-31 | $39.84M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |